A Study of MPT-0118 in Subjects With Advanced or Metastatic Refractory Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
Clinical Trials Related to Metastatic Cancer
Related studies linked through entity extraction aliases.
A Retro-/Prospective, Non-interventional, Cohort Study in Adult Patients With Locally Advanced or Metastatic Tumors With a Neurotrophic Tyrosine Receptor Kinase (NTRK) Gene Fusion, Treated With Larotrectinib
- Status
- COMPLETED
- Phase
- N/A
Circulating Tumor DNA as Marker for Response to Antineoplastic Treatment of Metastatic Cancer (FLUIDO)
- Status
- UNKNOWN
- Phase
- N/A
Predicting Disease Progression and/or Recurrence in Cancer
- Status
- COMPLETED
- Phase
- N/A
Randomized Clinical Trial of a Multi-Modal Palliative Care Intervention
- Status
- COMPLETED
- Phase
- NA
Advanced Lung Tumor Treated by Osimertinib Plus Anlotinib
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Prevention and Treatment of Complications of Endovascular Methods in Patients With Malignant Liver Tumors
- Status
- UNKNOWN
- Phase
- N/A
FS222 First in Human Study in Patients With Advanced Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
Metastatic Solid Cancer Clinical Trial
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Onapristone and Fulvestrant for ER+ HER2- Metastatic Breast Cancer After Endocrine Therapy and CDK4/6 Inhibitors (The SMILE Study)
- Status
- TERMINATED
- Phase
- PHASE2
A Clinical Trial Assessing BT-001 Alone and in Combination With Pembrolizumab in Metastatic or Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Assessment of the Prevalence of Sarcopenia in Early Palliative Cancer Patients
- Status
- COMPLETED
- Phase
- N/A
A Phase 2 Trial for Patients With Metastatic Solid Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Cohort Study of Beta-Glucan or Beta-Glucan Compound in Metastatic Cancers
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT141 in Patients With Unresectable or Metastatic CLDN18.2-positive Gastric, Pancreatic, Ovarian and Biliary Tract Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
OPTIMIzation of Treatment SElection and Follow up in Oligometastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Study of TJ210001 Administered in Subjects With Relapsed or Refractory Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Sym024 Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
LYT-200 Alone and in Combination With Chemotherapy or Tislelizumab in Patients With Locally Advanced or Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2